Semaglutide is a medication that has been approved for chronic weight management in adults who have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes).

Yes! Semaglutide has been approved for not only Type II diabetes management, but also for weight management.

Wegovy and Ozempic are not the same drug, but they both belong to a class of medications called glucagon-like peptide-1 receptor agonists (GLP-1 agonists). 

The generic name of Wegovy is semaglutide. It was approved by the U.S. Food and Drug Administration (FDA) in June 2021 for chronic weight management in adults with obesity or overweight individuals who have at least one weight-related condition. 

The generic name of Ozempic is semaglutide as well. Ozempic was initially approved by the FDA in 2017 as a treatment for type 2 diabetes. It is also a GLP-1 agonist, but it is used at a lower dose than Wegovy. Ozempic is administered as a once-weekly injection to help lower blood sugar levels in people with type 2 diabetes. However, it can also result in weight loss as a side effect.

Semaglutide works by suppressing appetite, leading to reduced calorie intake and promoting weight loss. It acts on the appetite control centers in the brain, helping people feel full and satisfied with smaller food portions.

Semaglutide for weight loss is injected once a week as a subcutaneous injection (under the skin) in the clinic located at 1100 Lake St, Suite 260 in Oak Park, Illinois.

Clinical trials have shown that semaglutide, in combination with lifestyle modifications, can lead to significant weight loss. On average, people taking semaglutide lost more weight than those on placebo. However, individual results may vary, and it is important to discuss weight loss expectations with your healthcare provider.

Semaglutide for weight loss is specifically approved for adults with obesity (BMI 30 or higher) or overweight individuals (BMI 27 or higher) with at least one weight-related condition. It is not intended for use in individuals without these specific criteria.

Common side effects of semaglutide for weight loss may include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These side effects are usually mild and tend to improve over time. However, it is important to consult with your healthcare provider if you experience any concerning or persistent side effects.

Semaglutide is typically used as a long-term treatment for weight management. Your healthcare provider will determine the duration of treatment based on your individual needs and goals.

The use of semaglutide in combination with other weight loss medications or programs has not been extensively studied. It is important to discuss with your healthcare provider if you are considering combining semaglutide with other weight loss strategies.

Weight regain is possible after discontinuing semaglutide. It is crucial to incorporate healthy lifestyle changes, such as a balanced diet and regular physical activity, to maintain weight loss achieved during semaglutide treatment.

The price noted has no hidden fees and includes your consultation with a medical provider as well as your monthly weekly injections and check-ins.

Midwest Alternative Treatment Clinic does not accept insurance, private or public. Patients are responsible for payment of services at time of visit.

Schedule your next injection as soon as possible and up to 5 days after your missed dose. If it has been more than 5 days, skip the missed dose and continue with regular schedule. It is not recommended to take an extra dose or double dose at any time.